RETRACTED: Ardissino et al. Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia. Int. J. Mol. Sci. 2023, 24, 7358.

Save

The journal retracts the article titled “Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia” [1], cited above.

Following publication, concerns were brought to the attention of the Editorial Office regarding the ethical oversight of the study and the completeness of the potential competing interest disclosures.

In accordance with the journal’s standard procedures, the Editorial Office and Editorial Board conducted an investigation, which identified inconsistencies between the description of the study and its reported design. A further assessment by the Editorial Board found no documented evidence that appropriate ethical review had been obtained prior to the commencement of the study. Although the authors cooperated with the investigation and provided supporting materials, the Editorial Board determined that the explanations and documentation provided did not sufficiently address the concerns identified.

As a result, the study was found to be non-compliant with MDPI’s policies on research involving human subjects. Therefore, the Editorial Board has decided to retract this article in accordance with MDPI’s retraction policy.

This retraction was approved by the Editor-in-Chief of the International Journal of Molecular Sciences.

The authors have been informed of this retraction and have indicated their disagreement with this decision.

Related articles

PubMed

Using Implementation Science to Improve Guidelines-Based Care to Lower Atherosclerosis Risk Due to Familial Hypercholesterolemia.

Purpose of the Review Implementation science, a multi-method research area that integrates input from constituents and content experts, has emerged as an important tool in improving implementation of evidence-based practices. This review summarizes three ongoing implementation studies focused on identification of patients with significantly increased risk for atherosclerotic cardiovascular disease (ASCVD) due to genomic risk such as familial hypercholesterolemia (FH) within a single health syst...

PubMed

Effectiveness and safety of atorvastatin/ ezetimibe fixed-dose combination in hypercholesterolemia: a systematic review and network meta-analysis.

Background Many patients fail to achieve low-density lipoprotein cholesterol (LDL-C) targets with statin monotherapy, calling for a combination of statins and ezetimibe. This systematic review and network meta-analysis evaluated the comparative effectiveness and safety of atorvastatin monotherapy, atorvastatin/ezetimibe free-equivalent combination (AS/EZ FEC), and fixed-dose combination (AS/EZ FDC) in patients with hypercholesterolemia. Methods Randomized controlled trials were retrieved from...